U.S. Markets closed
  • S&P Futures

    3,635.50
    +8.25 (+0.23%)
     
  • Dow Futures

    29,891.00
    +63.00 (+0.21%)
     
  • Nasdaq Futures

    12,193.50
    +41.25 (+0.34%)
     
  • Russell 2000 Futures

    1,852.10
    +7.50 (+0.41%)
     
  • Crude Oil

    46.04
    +0.33 (+0.72%)
     
  • Gold

    1,809.10
    +3.60 (+0.20%)
     
  • Silver

    23.44
    +0.08 (+0.36%)
     
  • EUR/USD

    1.1929
    +0.0010 (+0.0835%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.25
    -0.39 (-1.80%)
     
  • GBP/USD

    1.3393
    +0.0011 (+0.0804%)
     
  • USD/JPY

    104.3100
    -0.1300 (-0.1245%)
     
  • BTC-USD

    18,738.08
    -105.05 (-0.56%)
     
  • CMC Crypto 200

    368.00
    -2.51 (-0.68%)
     
  • FTSE 100

    6,391.09
    -41.08 (-0.64%)
     
  • Nikkei 225

    26,446.76
    +149.90 (+0.57%)
     

Prothena: 3Q Earnings Snapshot

·1 min read

DUBLIN (AP) _ Prothena Corp. (PRTA) on Wednesday reported a loss of $30.6 million in its third quarter.

On a per-share basis, the Dublin-based company said it had a loss of 77 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 68 cents per share.

The drug developer posted revenue of $157,000 in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $533,000.

Prothena shares have declined 12% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $13.94, a climb of 49% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PRTA at https://www.zacks.com/ap/PRTA